Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
4.480
+0.200 (4.67%)
At close: Feb 13, 2026, 4:00 PM EST
4.470
-0.010 (-0.22%)
After-hours: Feb 13, 2026, 7:37 PM EST
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $177.09 million as of February 13, 2026. Its market cap has increased by 4,525.27% in one year.
Market Cap
177.09M
Enterprise Value
169.68M
1-Year Change
4,525.27%
Ranking
Category
Stock Price
$4.48
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has increased from $41.18M to $177.09M, an increase of 330.03%. That is a compound annual growth rate of 42.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 177.09M | 60.37% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 187.20M |
| Ovid Therapeutics | 184.86M |
| Prelude Therapeutics | 183.75M |
| SAB Biotherapeutics | 183.29M |
| C4 Therapeutics | 183.17M |
| Galectin Therapeutics | 177.94M |
| Tiziana Life Sciences | 177.40M |
| Crescent Biopharma | 174.77M |